《瑞信窩輪》比亞迪急升藥明急跌,留意比迪牛67229、藥明牛57295
新能源汽車股比亞迪股份(1211)10月銷量按年增加88.1%,其中新能源汽車銷量,較去年同期增長約2.5倍,周四曾急升逾7%,高見313元以上。向上以挑戰320元為目標,支持或參考近期低位穩守的280元水平。看好可留意比迪購29298,行使價369.08元,22年2月到期。或比迪牛67229,收回價295.6元,行使價291.6元,22年4月到期。相反看淡可留意比迪沽23685,行使價250.00元,22年2月到期。或比迪熊55820,收回價328.00元,行使價332.00元,22年4月到期。
吉利汽車(0175)升逾1%,重上26元水平。看好可留意吉利購25407,行使價29.98元,22年1月到期。或吉利牛62738,收回價24.28元,行使價23.78元,22年4月到期。相反看淡可留意吉利沽29300,行使價23.23元,22年2月到期。或吉利熊66468,收回價27.90元,行使價28.40元,22年6月到期。
贛鋒鋰業(1772)大致靠穩,曾升逾1%至147元。向上阻力留意本周二高位157元,短期支持或參考140元水平。看好可留意贛鋒購28045,行使價166.88元,22年4月到期。
藥明生物(2269)突然捱沽,周四低位曾急捱逾9%,失守百元關口。觀望反彈,看好可留意藥明購28374,行使價125.1元,22年5月到期。或藥明牛57295,收回價98元,行使價96元,22年4月到期。相反或可考慮藥明熊67261,收回價120元,行使價122元,22年4月到期。
以上產品資料來源: 彭博資訊及瑞信網站cswarrants.com
(本結構性產品並無抵押品)
《瑞信香港認股證及牛熊證銷售主管何啟聰》
免責聲明:筆者為瑞士信貸(香港)有限公司的代表 ,並身為證監會持牌人,並無持有相關上市公司的任何財務權益。本文內容僅供參考,並不構成要約、建議或促使任何人士提呈買賣或認購任何證券。結構性產品價格可急升或急跌,投資者或會蒙受全盤損失。本產品並無抵押品。如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。牛熊證備強制贖回機制而可能被提早終止,屆時(i)N類牛熊證投資者將不獲發任何金額;而(ii)R類牛熊證之剩餘價值可能為零。有關恆生指數,恆生中國企業指數或恆生科技指數的免責聲明,請參閱上市文件。有關納斯達克100指數的免責聲明,請參閱上市文件。過往表現並不反映將來表現。投資前,投資者應瞭解風險,並諮詢專業顧問及查閱有關上市文件。瑞信之聯屬公司Credit Suisse Securities (Hong Kong) Limited為結構性產品之流通量提供者,亦可能是唯一報價者。本文任何內容概不構成投資、法律、會計或稅務意見、並無聲明任何投資或策略適合或符合閣下的個別情況。結構性產品交投量並不是結構性產品表現的指標,投資者不應僅依賴交投量歷史高位數據以釐定結構性產品日後的表現。~
重要聲明:
以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
![](/hk/assets/image/code.84ab0b.png)
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.